Literature DB >> 22249519

Nonpharmacological interventions for the prevention of type 2 diabetes mellitus.

Peter E Schwarz1, Colin J Greaves, Jaana Lindström, Thomas Yates, Melanie J Davies.   

Abstract

During the past decade, improved understanding of the pathophysiological mechanisms of diabetes development has resulted in advances in therapeutic concepts, but has also supported the potential for diabetes prevention through nonpharmacological means. At the beginning of the century, we experienced a shift in paradigm, as landmark studies have shown that diabetes mellitus is preventable with lifestyle intervention; moderate changes in diet and physical activity produce a substantial and sustained reduction in the incidence of type 2 diabetes mellitus (T2DM) for individuals with impaired glucose tolerance. This evidence must now be translated into clinical and public-health practice, but translational studies have varied in their ability to replicate the results of clinical trials. This variation reflects a number of challenging barriers for diabetes prevention in real-world clinical practice, which makes it necessary to focus on identifying efficient intervention methods and delivery mechanisms. Research is now focusing on these mechanisms, as well as on developing efficient screening and risk-identification strategies and realistic scenarios for public-health policy to implement diabetes prevention programs. In this Review, we will discuss these mechanisms and will consider the implications of diabetes prevention for public-health strategy and policy.

Entities:  

Mesh:

Year:  2012        PMID: 22249519     DOI: 10.1038/nrendo.2011.232

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  125 in total

1.  The performance of a risk score in predicting undiagnosed hyperglycemia.

Authors:  P J Park; S J Griffin; L Sargeant; N J Wareham
Journal:  Diabetes Care       Date:  2002-06       Impact factor: 19.112

2.  Global health governance and the challenge of chronic, non-communicable disease.

Authors:  Roger S Magnusson
Journal:  J Law Med Ethics       Date:  2010       Impact factor: 1.718

Review 3.  Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease.

Authors:  Shari S Bassuk; JoAnn E Manson
Journal:  J Appl Physiol (1985)       Date:  2005-09

4.  Can a screening programme for diabetes be applied to another population?

Authors:  C Glümer; K Borch-Johnsen; S Colagiuri
Journal:  Diabet Med       Date:  2005-09       Impact factor: 4.359

5.  Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D).

Authors:  Timo Saaristo; Leena Moilanen; Eeva Korpi-Hyövälti; Mauno Vanhala; Juha Saltevo; Leo Niskanen; Jari Jokelainen; Markku Peltonen; Heikki Oksa; Jaakko Tuomilehto; Matti Uusitupa; Sirkka Keinänen-Kiukaanniemi
Journal:  Diabetes Care       Date:  2010-07-27       Impact factor: 19.112

Review 6.  The European perspective of diabetes prevention.

Authors:  P E H Schwarz; F Muylle; P Valensi; M Hall
Journal:  Horm Metab Res       Date:  2008-07-11       Impact factor: 2.936

7.  The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes.

Authors:  Peter E H Schwarz; Jiang Li; Manja Reimann; Alta E Schutte; Antje Bergmann; Markolf Hanefeld; Stefan R Bornstein; Jan Schulze; Jaakko Tuomilehto; Jaana Lindström
Journal:  J Clin Endocrinol Metab       Date:  2008-12-23       Impact factor: 5.958

Review 8.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

Review 9.  Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions.

Authors:  Colin J Greaves; Kate E Sheppard; Charles Abraham; Wendy Hardeman; Michael Roden; Philip H Evans; Peter Schwarz
Journal:  BMC Public Health       Date:  2011-02-18       Impact factor: 3.295

10.  MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.

Authors:  Dwi Setyowati Karolina; Arunmozhiarasi Armugam; Subramaniam Tavintharan; Michael T K Wong; Su Chi Lim; Chee Fang Sum; Kandiah Jeyaseelan
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

View more
  40 in total

1.  [Screening and prevention of diabetes].

Authors:  P E H Schwarz
Journal:  Internist (Berl)       Date:  2015-10       Impact factor: 0.743

2.  Postprandial glucose and insulin levels in type 2 diabetes mellitus patients after consumption of ready-to-eat mixed meals.

Authors:  Yannis Manios; George Moschonis; Christina Mavrogianni; Konstantina Tsoutsoulopoulou; Stergios Kogkas; Christina-Paulina Lambrinou; Eirini Efstathopoulou
Journal:  Eur J Nutr       Date:  2016-02-26       Impact factor: 5.614

3.  Diabetes: T2DM--will tertiary prevention solve the problem?

Authors:  Adrian Bauman; Alexis St George
Journal:  Nat Rev Endocrinol       Date:  2013-02-26       Impact factor: 43.330

4.  Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study.

Authors:  Vera Schmid; Robert Wagner; Corinna Sailer; Louise Fritsche; Konstantinos Kantartzis; Andreas Peter; Martin Heni; Hans-Ulrich Häring; Norbert Stefan; Andreas Fritsche
Journal:  Diabetologia       Date:  2017-08-24       Impact factor: 10.122

5.  A Prospective Programmatic Cost Analysis of Fuel Your Life: A Worksite Translation of DPP.

Authors:  Justin B Ingels; Rebecca L Walcott; Mark G Wilson; Phaedra S Corso; Heather M Padilla; Heather Zuercher; David M DeJoy; Robert J Vandenberg
Journal:  J Occup Environ Med       Date:  2016-11       Impact factor: 2.162

6.  A simple Indian diabetes risk score could help identify nondiabetic individuals at high risk of non-alcoholic fatty liver disease (CURES-117).

Authors:  Viknesh Prabu Anbalagan; Vijayachandrika Venkataraman; Mamilla Vamsi; Mohan Deepa; Viswanathan Mohan
Journal:  J Diabetes Sci Technol       Date:  2012-11-01

7.  Self-reported eating speed in relation to non-alcoholic fatty liver disease in adults.

Authors:  Saehyun Lee; Byung-Joon Ko; Younghoon Gong; Kyungdo Han; Anna Lee; Byoung-Duck Han; Yeo Joon Yoon; Siyoung Park; Jung-Hyun Kim; Christos S Mantzoros
Journal:  Eur J Nutr       Date:  2015-02-04       Impact factor: 5.614

Review 8.  The European perspective of diabetes prevention: the need for individualization of diabetes prevention.

Authors:  G Müller; G Weser; P E H Schwarz
Journal:  J Endocrinol Invest       Date:  2013-05       Impact factor: 4.256

9.  Diabetes prevention: global health policy and perspectives from the ground.

Authors:  Michael Bergman; Martin Buysschaert; Peter Eh Schwarz; Ann Albright; Km Venkat Narayan; Derek Yach
Journal:  Diabetes Manag (Lond)       Date:  2012

10.  A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes.

Authors:  Norbert Stefan; Harald Staiger; Robert Wagner; Jürgen Machann; Fritz Schick; Hans-Ulrich Häring; Andreas Fritsche
Journal:  Diabetologia       Date:  2015-09-24       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.